Wells Fargo & Company »

Checkpoint Therapeutics shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Checkpoint Therapeutics (CKPT) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Checkpoint Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Checkpoint Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Checkpoint Therapeutics by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $39k 17k 2.29
2023-09-30 $27k 16k 1.70
2023-06-30 $20k 7.9k 2.47
2022-12-31 $249 49 5.10

More positions owned by Wells Fargo & Company

Microsoft Corporation Put Option (MSFT)
Apple (AAPL)
Ishares Tr Russell 2000 Etf (IWM)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Ishares Tr Core S&p500 Etf (IVV)
Amazon Put Option (AMZN)
Vanguard Index Fds Mid Cap Etf Put Option (VO)
Ishares Tr Core Us Aggbd Et (AGG)
Ishares Tr Core S&p Ttl Stk (ITOT)
UnitedHealth Call Option (UNH)
JPMorgan Chase & Co. Put Option (JPM)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Johnson & Johnson (JNJ)

View all positions for Wells Fargo & Company

Top funds holding Checkpoint Therapeutics

Vanguard Group
National Asset Management
Advisor Group Holdings
D. E. Shaw & Co
Pvg Asset Management
Citadel Advisors
Legacy Wealth Asset Management
Royal Bank of Canada
Park Avenue Securities
Wealth Enhancement Advisory Services
Jane Street
Lindbrook Capital
Rsm Us Wealth Management
Wells Fargo & Company
Emfo

View all funds holding Checkpoint Therapeutics